CMS yesterday updated its FAQ for state Medicaid and Children’s Health Insurance Program agencies, answering questions related to flexibilities related to managed care, benefits, financing, Section 1115 demonstrations, and Section 1135 waivers offered as part of the president’s declaration of a national emergency. 

The agency also clarified coverage of COVID-19 diagnosis and treatment by catastrophic health plans. The document aligns with guidance released last week by the Internal Revenue Service, which gave high deductible health plans flexibility to provide COVID-19 diagnosis and treatment benefits without deductibles or cost-sharing.

Related News Articles

Headline
The National Institutes of Health has halted a clinical trial evaluating the effectiveness of COVID-19 convalescent plasma in emergency department patients…
Headline
President Biden today announced a major partnership between Johnson & Johnson and Merck to manufacture the latest COVID-19 vaccine to be authorized for…
Headline
The AHA, American Medical Association, American Health Care Association, National Association for Home Care & Hospice, National Hospice and Palliative Care…
Headline
The federal government has agreed to purchase at least 100,000 doses of the combination monoclonal antibody therapy bamlanivimab and etesevimab, Eli Lilly…
Headline
The Food and Drug Administration Friday granted an emergency use authorization for Johnson & Johnson’s single-dose COVID-19 vaccine. Following the EUA’s…
Headline
The House of Representatives Saturday voted 219-212 to approve a modified version of the American Rescue Plan Act of 2021, legislation to provide…